Tempus AI (TEM)
52.26
+4.75 (10.00%)
Upcoming Events
Latest Headlines
Form 4 Tempus AI, Inc. For: Jun 01 Filed by: Epstein David R
June 3, 2026 4:29 PM - SEC Filing
Tempus launches open-source digital pathology consortium with Yale, MSK
June 3, 2026 8:31 AM - StreetInsider
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
June 3, 2026 8:30 AM - BizWire
Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
June 2, 2026 6:50 AM - StreetInsider
Wolfe Research Assumes Tempus AI Inc (TEM) at Peerperform
June 1, 2026 4:23 PM - StreetInsider
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
June 1, 2026 8:30 AM - BizWire
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
May 31, 2026 8:30 AM - BizWire
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
May 30, 2026 8:30 AM - BizWire
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
May 30, 2026 8:00 AM - BizWire
Form 4 Tempus AI, Inc. For: May 27 Filed by: LEFKOFSKY ERIC P
May 29, 2026 4:15 PM - SEC Filing
Tempus AI shares initial results from multimodal foundation model for oncology
May 29, 2026 9:15 AM - StreetInsider
Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology
May 29, 2026 9:15 AM - BizWire
Tempus receives FDA approval for tumor-only xT CDx genomic test
May 29, 2026 8:15 AM - StreetInsider
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
May 29, 2026 8:15 AM - BizWire
Tempus expands AI platform to six new cancer types for clinical insights
May 28, 2026 8:31 AM - StreetInsider
Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology
May 28, 2026 8:30 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
May 27, 2026 4:45 PM - SEC Filing
Tempus upgrades Hub platform with generative AI clinical tools
May 27, 2026 8:34 AM - StreetInsider
Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows
May 27, 2026 8:33 AM - BizWire
Form 4 Tempus AI, Inc. For: May 21 Filed by: Belcher Eric D
May 26, 2026 9:46 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 21 Filed by: Frederick Wayne A.I.
May 26, 2026 9:45 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 21 Filed by: Epstein David R
May 26, 2026 9:45 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 21 Filed by: Gottlieb Scott
May 26, 2026 9:45 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 21 Filed by: Leonsis Theodore
May 26, 2026 9:45 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 21 Filed by: West Nadja
May 26, 2026 9:45 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 21 Filed by: BARRIS PETER J
May 26, 2026 9:45 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 21 Filed by: Doudna Jennifer A
May 26, 2026 9:45 PM - SEC Filing
Tempus AI to present 37 research abstracts at 2026 ASCO meeting
May 26, 2026 8:31 AM - StreetInsider
Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 26, 2026 8:30 AM - BizWire
Form 8-K Tempus AI, Inc. For: May 21
May 22, 2026 4:01 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 19 Filed by: Polovin Andrew
May 21, 2026 5:06 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 19 Filed by: Rogers James William
May 21, 2026 5:06 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 19 Filed by: Schoenherr Thomas Edward
May 21, 2026 5:06 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 19 Filed by: Fukushima Ryan
May 21, 2026 5:06 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 19 Filed by: Bartolucci Ryan M
May 21, 2026 5:06 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 19 Filed by: LEFKOFSKY ERIC P
May 21, 2026 5:06 PM - SEC Filing
Tempus launches ArteraAI prostate test for metastatic patients
May 21, 2026 8:31 AM - StreetInsider
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use
May 21, 2026 8:30 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: Bartolucci Ryan M
May 20, 2026 5:15 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Rogers James William
May 20, 2026 5:13 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Phelps Erik
May 20, 2026 5:11 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
May 20, 2026 5:10 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Polovin Andrew
May 20, 2026 5:07 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
May 20, 2026 5:06 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
May 20, 2026 5:04 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 14 Filed by: Fukushima Ryan
May 15, 2026 5:03 PM - SEC Filing
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience
May 14, 2026 8:30 AM - BizWire
Tempus AI completes $460 million convertible notes offering
May 13, 2026 6:10 AM - StreetInsider
Form 8-K Tempus AI, Inc. For: May 07
May 13, 2026 6:03 AM - SEC Filing
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026 8:30 AM - Globe NewsWire
Tempus AI Inc (TEM) PT Lowered to $64 at H.C. Wainwright
May 11, 2026 6:58 AM - StreetInsider
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”
May 11, 2026 6:00 AM - BizWire
Tempus prices $400 million convertible notes offering
May 8, 2026 1:00 AM - StreetInsider
Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
May 8, 2026 1:00 AM - BizWire
Form SCHEDULE 13G/A Tempus AI, Inc. Filed by: BAILLIE GIFFORD & CO
May 7, 2026 10:05 AM - SEC Filing
Tempus AI announces $350 million convertible notes offering
May 7, 2026 7:11 AM - StreetInsider
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
May 7, 2026 7:11 AM - BizWire
Form 4 Tempus AI, Inc. For: May 04 Filed by: Bartolucci Ryan M
May 6, 2026 4:30 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 04 Filed by: Schoenherr Thomas Edward
May 6, 2026 4:30 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 04 Filed by: Rogers James William
May 6, 2026 4:30 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 04 Filed by: Polovin Andrew
May 6, 2026 4:30 PM - SEC Filing
Form 4 Tempus AI, Inc. For: May 04 Filed by: Fukushima Ryan
May 6, 2026 4:30 PM - SEC Filing
Lucent Diagnostics partners with Tempus AI for Alzheimer's blood testing
May 6, 2026 8:02 AM - StreetInsider
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows
May 6, 2026 8:00 AM - BizWire
Tempus AI Inc (TEM) PT Lowered to $59 at Baird
May 6, 2026 6:44 AM - StreetInsider
Tempus AI Inc (TEM) PT Raised to $68 at TD Cowen
May 6, 2026 5:57 AM - StreetInsider
Form 10-Q Tempus AI, Inc. For: Mar 31
May 5, 2026 4:07 PM - SEC Filing
Tempus AI, Inc (TEM) Misses Q1 EPS by 61c, provides guidance
May 5, 2026 4:06 PM - StreetInsider
Form 8-K Tempus AI, Inc. For: May 05
May 5, 2026 4:03 PM - SEC Filing
Tempus Reports First Quarter 2026 Results
May 5, 2026 4:01 PM - BizWire
Form 4 Tempus AI, Inc. For: Apr 28 Filed by: LEFKOFSKY ERIC P
April 30, 2026 4:31 PM - SEC Filing
Tempus to Host Inaugural Investor Day on May 29, 2026
April 29, 2026 8:30 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
April 28, 2026 4:42 PM - SEC Filing
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026
April 28, 2026 8:30 AM - BizWire
Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights
April 23, 2026 11:45 AM - BizWire
Tempus partners with USC medical school to integrate AI precision medicine
April 23, 2026 8:30 AM - StreetInsider
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine
April 23, 2026 8:30 AM - BizWire
Tempus to Report First Quarter 2026 Financial Results on May 5
April 21, 2026 8:30 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: Doudna Jennifer A
April 15, 2026 4:40 PM - SEC Filing
Tempus and Predicta partner on blood cancer genome testing assay
April 15, 2026 8:32 AM - StreetInsider
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
April 15, 2026 8:30 AM - BizWire
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
April 14, 2026 8:30 AM - BizWire
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care
April 13, 2026 8:30 AM - BizWire
TD Cowen Upgrades Tempus AI Inc (TEM) to Buy
April 13, 2026 5:30 AM - StreetInsider
Jefferies Starts Tempus AI Inc (TEM) at Underperform
April 13, 2026 3:24 AM - StreetInsider
Tempus expands multi-year collaboration with Gilead for oncology research
April 9, 2026 8:30 AM - StreetInsider
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
April 9, 2026 8:30 AM - BizWire
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026 4:01 PM - BizWire
Form ARS Tempus AI, Inc. For: Dec 31
April 7, 2026 4:11 PM - SEC Filing
Form DEFA14A Tempus AI, Inc.
April 7, 2026 4:09 PM - SEC Filing
Form DEF 14A Tempus AI, Inc. For: May 21
April 7, 2026 4:09 PM - SEC Filing
Tempus AI shows improved heart valve treatment with alerts
April 1, 2026 8:33 AM - StreetInsider
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
April 1, 2026 8:30 AM - BizWire
Legendary Investors are Rotating Capital into AI Powered Biotech
March 30, 2026 9:15 AM - StreetInsider
Tempus AI Inc (TEM) PT Lowered to $60 at Guggenheim
March 30, 2026 7:10 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Mar 26 Filed by: LEFKOFSKY ERIC P
March 27, 2026 9:46 PM - SEC Filing
Form SCHEDULE 13G/A Tempus AI, Inc. Filed by: VANGUARD GROUP INC
March 27, 2026 1:33 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
March 26, 2026 4:28 PM - SEC Filing
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
March 17, 2026 8:30 AM - BizWire
Nvidia’s Bet on Digital Biology and Stocks That Could Ride the Wave
March 16, 2026 10:00 AM - StreetInsider
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
March 11, 2026 8:30 AM - BizWire
Tempus AI Inc (TEM) PT Raised to $95 at H.C. Wainwright
March 10, 2026 7:21 AM - StreetInsider
Full Article List
